These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12183652)

  • 1. Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence.
    Stout BD; Clarke WP; Berg KA
    J Pharmacol Exp Ther; 2002 Sep; 302(3):957-62. PubMed ID: 12183652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.
    Berg KA; Maayani S; Goldfarb J; Scaramellini C; Leff P; Clarke WP
    Mol Pharmacol; 1998 Jul; 54(1):94-104. PubMed ID: 9658194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
    Berg KA; Cropper JD; Niswender CM; Sanders-Bush E; Emeson RB; Clarke WP
    Br J Pharmacol; 2001 Sep; 134(2):386-92. PubMed ID: 11564657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation.
    Berg KA; Stout BD; Maayani S; Clarke WP
    J Pharmacol Exp Ther; 2001 Nov; 299(2):593-602. PubMed ID: 11602671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists.
    Berg KA; Maayani S; Goldfarb J; Clarke WP
    Ann N Y Acad Sci; 1998 Dec; 861():104-10. PubMed ID: 9928246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel actions of inverse agonists on 5-HT2C receptor systems.
    Berg KA; Stout BD; Cropper JD; Maayani S; Clarke WP
    Mol Pharmacol; 1999 May; 55(5):863-72. PubMed ID: 10220565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
    Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves.
    Kurrasch-Orbaugh DM; Watts VJ; Barker EL; Nichols DE
    J Pharmacol Exp Ther; 2003 Jan; 304(1):229-37. PubMed ID: 12490596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist-induced functional desensitization of recombinant human 5-HT2 receptors expressed in CHO-K1 cells.
    Porter RH; Malcolm CS; Allen NH; Lamb H; Revell DF; Sheardown MJ
    Biochem Pharmacol; 2001 Aug; 62(4):431-8. PubMed ID: 11448452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoromethylindone (SB 243213) on 5-hydroxytryptamine(2C) receptor-mediated responses.
    Berg KA; Navailles S; Sanchez TA; Silva YM; Wood MD; Spampinato U; Clarke WP
    J Pharmacol Exp Ther; 2006 Oct; 319(1):260-8. PubMed ID: 16807362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin (5-HT) receptor subtypes mediate specific modes of 5-HT-induced signaling and regulation of neurosecretion in gonadotropin-releasing hormone neurons.
    Wada K; Hu L; Mores N; Navarro CE; Fuda H; Krsmanovic LZ; Catt KJ
    Mol Endocrinol; 2006 Jan; 20(1):125-35. PubMed ID: 16109737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal regulation of agonist efficacy at 5-hydroxytryptamine (5-HT)1A and 5-HT 1B receptors.
    Berg KA; Evans KL; Cropper JD; Clarke WP
    J Pharmacol Exp Ther; 2003 Jan; 304(1):200-5. PubMed ID: 12490592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [3H]phosphatidylinositol depletion.
    Cussac D; Newman-Tancredi A; Quentric Y; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):221-3. PubMed ID: 10685880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of regulation of agonist efficacy at the 5-HT(1A) receptor by phospholipid-derived signaling components.
    Evans KL; Cropper JD; Berg KA; Clarke WP
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1025-35. PubMed ID: 11356925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.
    Berg KA; Maayani S; Clarke WP
    Mol Pharmacol; 1996 Oct; 50(4):1017-23. PubMed ID: 8863849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.
    Newman-Tancredi A; Cussac D; Quentric Y; Touzard M; Verrièle L; Carpentier N; Millan MJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):815-22. PubMed ID: 12388668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid desensitization of serotonin 5-HT2C receptor-stimulated intracellular calcium mobilization in CHO cells transfected with cloned human 5-HT2C receptors.
    Akiyoshi J; Nishizono A; Yamada K; Nagayama H; Mifune K; Fujii I
    J Neurochem; 1995 Jun; 64(6):2473-9. PubMed ID: 7760026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human 5-HT4(d) receptor desensitization in CHO cells.
    Mialet J; Fischmeister R; Lezoualc'h F
    Br J Pharmacol; 2003 Feb; 138(3):445-52. PubMed ID: 12569069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between effectors linked to serotonin receptors.
    Berg KA; Maayani S; Clarke WP
    Ann N Y Acad Sci; 1998 Dec; 861():111-20. PubMed ID: 9928247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.